Bringing Clinical Trials to Life

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends…More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…More...

Rare & Orphan Disease

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…More...

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….More...

6/24/2018 - 6/28/2018 : 2018 DIA Annual Meeting Booth # 1104 More...

6/20/2018: Leaders from Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies, will attend the annual DIA Conference in Boston, June 24-28, 2018. More ...

5/31/2018: DIA 2018 Is On The Horizon! - Are you planning to attend DIA 2018 this year? We would love to see you there! Synteract will be exhibiting in Boston in booth #1104, June 24-28th.

Synteract Blog 

6/25/2018: Thank you CISCRP for putting on a successful 5K this morning! Great job to our team members that got up early and completed the run! #whysynteact #dia #CISCRP #Medheroappreciation

Synteract on LinkedIn

6/25/2018: Thank you @CISCRP for putting on a successful 5K this morning! Great job to our team members that got up early and… https://t.co/jlHobXamcj

Synteract Twitter Feed
x

Contact Synteract

Tell us how to stay in touch with you:

*Required